The Limitations of Traditional Psychiatry
Psychiatric outcomes for serious mental disorders continue to disappoint. Large studies published between 2003 and 2007 showed less than one third of patients classified with major depression, bipolar disorder or schizophrenia achieved satisfactory outcomes [1-3]. These studies were supervised by psychiatric experts and represented best psychiatric practice.

The director of the U.S National Institute of Mental Health [NIMH], Tom Insel M.D. has stated "...these trials used evidence-based treatments of well-documented efficacy that were administered with optimum clinical standards. The results show the significant limitations of current pharmacological interventions [4]." Since the publication of the Diagnostic & Statistical Manual of Mental Disorders (D.S.M.-5), the newest edition, Dr. Insel has affirmed that recasting symptoms and behaviors into different syndromes isn't advancing the medical treatment of mental disorders.

Sadly, these unsatisfactory results from the psychiatric model predict that many people with mental disorders will continue to suffer.

Fundamental flaws in the traditional psychiatric model include:

  • absence of a comprehensive physical assessment and monitoring of physical findings
  • absence of individual neurophysiologic data
  • equating mental distress with a specific psychiatric disorder
  • trying to sort mental distress without measures of individual physiology... A categorical mistake.

Medical treatment is organized by physiologic differences. Since the brain automatically balances itself and other physical systems 24/7, it follows that psychiatric medical treatment should be ordered by physiologic differences in all physical systems. Mismatches between prescribed medications and neurophysiology result from using psychological terms to explain complex physiology including neuro-physiology. This approach violates the medical model.

The brain automatically balances itself and other physical systems; thus any variations in a person's physical systems are important clues to the causal neurophysiology. Medical research and EEG/QEEG experience has taught Dr. Emory to use Axis III physical findings and EEG/QEEG data to organize each person's treatment. This is a fact driven means of improving variant brain function that is causing a physical and/or mental distress.

Citations
  • Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis CE, Lebowitz BD, Severe
    J, Hsiao JK; Clinical Anti-psychotic Trial of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic
    drugs in patients with chronic schizophrenia. N Engl J Med. 2005; 353(12):1209-1223
  • Warden D, Rush AJ, Trivedi MH, Fava M, Wisniewski SR. The STAR*D Project results: a comprehensive review of findings.
    Curr Psychiatry Rep. 2007; 9(6):449-459
  • Thase ME. STEP-BD and bipolar depression: what have we learned? Curr Psychiatry Rep. 2007; 9(6):497-503
  • Insel, T. R. (2009, February). Translating scientific opportunity into public health impact. Archives of General Psychiatry,
    66(2), 128-133.
Latest News

March 2016

Monoamine Oxidase Inhibition in a Patient With Type I Diabetes and Depression Emory H. and Mizrahi, N, // (Journal of Diabetes Science and Technology. DOI: 10.1177/1932296816638106)


January 2016

Dr. Hamlin Emory Speaks in Washington State - Finding and Fixing Unrecognized Brain Differences
https://vimeo.com/154468931



Patient Testimonials